Photodynamic therapy for early stage squamous cell carcinoma of the lung

Mayo Clinic Proceedings

Volumn 72, Issue 7, 1997, Pages 595-602

  Cortese, Denis A ^a   Edell, Eric S ^a   Kinsey, James H ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMATOPORPHYRIN DERIVATIVE;

ARTICLE; BRONCHOSCOPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; LUNG CARCINOMA; OCCULT CANCER; PHOTODYNAMIC THERAPY; SQUAMOUS CELL CARCINOMA;

EID: 0030764445     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/72.7.595     Document Type: Article

References (34)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. ÇA Cancer J Clin 1996;46:5-27
2. Gail MH, Eagan RT, Feld R, Ginsberg R, Goodell B, Hill L, et al. Prognostic factors in patients with resected stage I non-small cell lung cancer: a report from the Lung Cancer Study Group. Cancer 1984;54:1802-1813
3. Pairolero PC, Williams DE, Bergstralh EJ, Piehler JM, Bernatz PE, Payne WS. Postsurgical stage I bronchogenie carcinoma: morbid implications of recurrent disease. Ann Thorac Surg 1984;38:331-338
4. Williams DE, Pairolero PC, Davis CS, Bernatz PE, Payne WS. Taylor WE, et al. Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg 1981:82:70-76
5. Cortese DA, Pairolero PC, Bergstralh EJ, Woolner LB, Uhlenhopp MA, Piehler JM, et al. Roentgenographically occult lung cancer: a ten-year experience. J Thorac Cardiovasc Surg 1983;86:373-380
6. Hayata Y, Funatsu H. Kato H, Saito Y, Sawamura K, Furose K. Results of lung cancer screening programs in Japan. Rec Results Cancer Res 1982;82:163-173
7. Fontana RS, Sanderson DR, Woolner LB. Taylor WF, Miller WE. Muhm JR. Lung cancer screening: the Mayo program. JOccupMed 1986;28:746-750
8. Ball WC Jr. Frost JK, Tockman MS, Levin M. Screening for lung cancer: the effect of 5-7 years of periodic roentgenographic and cytologie examinations on detection, survival and mortality from lung cancer [abstract]. Am Rev Respir Dis 1985;131(Suppl):A84
9. Errett LE, Wilson J, Chiu RC, Munro DD. Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor-risk patients. J Thorac Cardiovasc Surg 1985:90:656-661
10. Little AG. DeMeester TR, Ferguson MK, Skinner DB. Hoffman PC. Skosey C. et al. Modified stage I (T,N()M(1, TJM M()), nonsmall cell lung cancer: treatment results, recurrent patterns, and adjuvant immunotherapy. Surgery 1986:100:621-628
11. Crabbe MM, Patrissi GA, Fontenelle LJ. Minimal resection for bronchogenic carcinoma: an update. Chest 1991;99:1421-1424
12. lascone C. DeMeester TR, Albertucci M, Little AG, Golomb HM. Local recurrence of resectable non-oat cell carcinoma of the lung: a warning against conservative treatment for N and N, disease. Cancer 1986;57:471-476
13. Ginsberg RJ, Hill LD, Eagan RT, Thomas P, Mountain CF, Deslauriers J, et al. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 1983:86:654-658
14. Cortese DA. Kinsey JH. Endoscopie management of lung cancer with hematoporphyrin derivative phototherapy. Mayo ClinProc 1982:57:543-547
15. Cortese DA, Kinsey JH. Hematoporphyrin derivative phototherapy in the treatment of bronchogenic carcinoma. Chest 1984:86:8-13
16. Cortese DA. Endobronchial management of lung cancer. Chest 1986;89(Suppl):234S-236S
17. Edell ES, Cortese DA. Bronchoscopic phototherapy with hematoporphyrin derivative for treatment of localized bronchogenic carcinoma: a 5-year experience. Mayo Clin Proc 1987;62:8-14
18. Edell ES, Cortese DA. Bronchoscopic localization and treatment of occult lung cancer. Chest 1989;96:919-921
19. Edell ES, Cortese DA. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest 1992; 102:13191322
20. Hayata Y, Kato H, Konaka C, Ono J, Takizawa N. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest 1982;81:269-277
21. Hayata Y, Kato H, Konaka C, Amemiya R, Ono J, Ogawa I, et al. Photoradiation therapy with hematoporphyrin derivative in early and stage 1 lung cancer. Chest 1984;86:169-177
22. Kato H, Konaka C, Ono J, Kawate N, Nishimiya K, Shinohara H, et al. Preoperative laser photodynamic therapy in combination with operation in lung cancer. J Thorac Cardiovasc Surg 1985;90:420-429
23. Kato H, Konaka C, Kawate N, Shinohara H, Konoshita K, Noguchi M, et al. Five-year disease-free survival of a lung cancer patient treated only by photodynamic therapy. Chest 1986;90:768-770
24. Kato H, Kawate N, Kinoshita K, Yamamoto H, Furukawa K, Hayata Y. Photodynamic therapy of early-stage lung cancer. Ciba Found Symp 1989; 146:183-194
25. Sutedja T, Baas P, Stewart F, van Zandwijk N. A pilot study of photodynamic therapy in patients with inoperable nonsmall cell lung cancer. Eur J Cancer 1992;28A:13701373
26. Lipson RL, Baldes EJ, Olsen AM. The use of a derivative of hematoporphyrin in tumor detection. J Natl Cancer Inst 1961;26:1-11
27. Woolner LB, Fontana RS, Cortese DA, Sanderson DR, Bernatz PE, Payne WS, et al. Roentgenographically occult lung cancer: pathologic findings and frequency of multicentricity during a 10-year period. Mayo Clin Proc 1984;59:453-466
28. Ono R, Ikeda S, Suemasu K. Hematoporphyrin derivative photodynamic therapy in roentgenographically occult carcinoma of the tracheobronchial tree. Cancer 1992;69:16961701
29. Furuse K, Fukuoka M, Kato H, Horai T, Kubota K, Kodama N, et al. A prospective phase II study on photodynamic therapy with Photofrin II for centrally located earlystage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group. J Clin Oncol 1993;! 1:18521857
30. Sutedja T, Lam S, LeRiche JC, Postmus PE. Response and pattern of failure after photodynamic therapy for intraluminal stage I lung cancer. J Bronchol 1994; 1:295-298
31. Slaughter DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953;6:963968
32. Christensen PH, Joergensen K, Munk J, Oesterlind A. Hyperfrequency of pulmonary cancer in a population of 415 patients treated for laryngeal cancer. Laryngoscope 1987;97:612-614
33. van Velzen E, Snijder RJ, de la Rivière AB, Eibers HJJ, van den Bosch JMM. Type of lymph node involvement influences survival rates in T1N1MO non-small cell lung carcinoma: lymph node involvement by direct extension compared with lobar and hilar node métastases. Chest 1996;! 10:1469-1473
34. Mao L, Hruban RH, Boyle JO, Tockman M, Sidransky D. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res 1994;54:16341637